Ronald Peck

1.6k total citations
15 papers, 1.2k citations indexed

About

Ronald Peck is a scholar working on Oncology, Dermatology and Cancer Research. According to data from OpenAlex, Ronald Peck has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 4 papers in Dermatology and 3 papers in Cancer Research. Recurrent topics in Ronald Peck's work include Cancer Treatment and Pharmacology (11 papers), HER2/EGFR in Cancer Research (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Ronald Peck is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), HER2/EGFR in Cancer Research (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Ronald Peck collaborates with scholars based in United States, Germany and France. Ronald Peck's co-authors include Linda T. Vahdat, Eva Thomas, Gabriel N. Hortobágyi, Edith A. Perez, Joseph A. Sparano, Patrice Viens, Brian P. Mullaney, Xavier Pivot, Guillermo Lerzo and Linda D. Bosserman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Pharmacology & Therapeutics.

In The Last Decade

Ronald Peck

15 papers receiving 1.2k citations

Peers

Ronald Peck
Maureen Edgerly United States
Robert L. DeWitty United States
P. Hupperets Netherlands
Chantal Bernard-Marty Belgium
Vito Spataro Switzerland
Cynthia Osborne United States
A. Bowman United Kingdom
Andrea Piga Italy
J. Wendall Goodwin United States
D. Serin France
Maureen Edgerly United States
Ronald Peck
Citations per year, relative to Ronald Peck Ronald Peck (= 1×) peers Maureen Edgerly

Countries citing papers authored by Ronald Peck

Since Specialization
Citations

This map shows the geographic impact of Ronald Peck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Peck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Peck more than expected).

Fields of papers citing papers by Ronald Peck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Peck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Peck. The network helps show where Ronald Peck may publish in the future.

Co-authorship network of co-authors of Ronald Peck

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Peck. A scholar is included among the top collaborators of Ronald Peck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Peck. Ronald Peck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Curtis, J. Randall, Lois Downey, Anthony L. Back, et al.. (2018). Effect of a Patient and Clinician Communication-Priming Intervention on Patient-Reported Goals-of-Care Discussions Between Patients With Serious Illness and Clinicians. JAMA Internal Medicine. 178(7). 930–930. 155 indexed citations
2.
Stahl, Maximilian, Richard Gedrich, Ronald Peck, Theresa LaVallee, & Joseph P. Eder. (2016). Targeting KIT on Innate Immune Cells to Enhance the Antitumor Activity of Checkpoint Inhibitors. Immunotherapy. 8(7). 767–774. 10 indexed citations
3.
Berman, David M., Alan J. Korman, Ronald Peck, et al.. (2014). The development of immunomodulatory monoclonal antibodies as a new therapeutic modality for cancer: The Bristol-Myers Squibb experience. Pharmacology & Therapeutics. 148. 132–153. 47 indexed citations
4.
Corey‐Lisle, Patricia K., Ronald Peck, Pralay Mukhopadhyay, et al.. (2011). Q‐TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer. Cancer. 118(2). 461–468. 19 indexed citations
5.
6.
7.
Sparano, Joseph A., Eduard Vrdoljak, O. Rixe, et al.. (2010). Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane. Journal of Clinical Oncology. 28(20). 3256–3263. 175 indexed citations
8.
Bunnell, Craig A., Linda T. Vahdat, Lee S. Schwartzberg, et al.. (2008). Phase I/II Study of Ixabepilone plus Capecitabine in Anthracycline–Pretreated/Resistant and Taxane-Resistant Metastatic Breast Cancer. Clinical Breast Cancer. 8(3). 234–241. 48 indexed citations
9.
Faivre, Sandrine, Catherine Delbaldo, Valérie Boige, et al.. (2008). Safety of repeated administrations of ixabepilone given as a 3-hour infusion every other week in combination with irinotecan in patients with advanced malignancies. European Journal of Cancer. 44(5). 674–682. 7 indexed citations
10.
Vansteenkiste, Johan, Primo N. Lara, Thierry Le Chevalier, et al.. (2007). Phase II Clinical Trial of the Epothilone B Analog, Ixabepilone, in Patients With Non–Small-Cell Lung Cancer Whose Tumors Have Failed First-Line Platinum-Based Chemotherapy. Journal of Clinical Oncology. 25(23). 3448–3455. 109 indexed citations
11.
Aghajanian, Carol, Howard A. Burris, Suzanne F. Jones, et al.. (2007). Phase I Study of the Novel Epothilone Analog Ixabepilone (BMS-247550) in Patients With Advanced Solid Tumors and Lymphomas. Journal of Clinical Oncology. 25(9). 1082–1088. 77 indexed citations
12.
Roché, Henri, Louise Yelle, Francesco Cognetti, et al.. (2007). Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, As First-Line Therapy in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline Chemotherapy. Journal of Clinical Oncology. 25(23). 3415–3420. 174 indexed citations
13.
Perez, Edith A., Guillermo Lerzo, Xavier Pivot, et al.. (2007). Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and Capecitabine. Journal of Clinical Oncology. 25(23). 3407–3414. 302 indexed citations
14.
15.
Okamatsu, Shuichi, Ronald Peck, & Allan M. Lefer. (1981). Effects of Calcium Channel Blockers on Arachidonate-Induced Sudden Death in Rabbits. Experimental Biology and Medicine. 166(4). 551–555. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maureen Edgerly Breakdown of academic impact, for papers by Robert L. DeWitty Breakdown of academic impact, for papers by P. Hupperets Breakdown of academic impact, for papers by Chantal Bernard-Marty Breakdown of academic impact, for papers by Vito Spataro Breakdown of academic impact, for papers by Cynthia Osborne Breakdown of academic impact, for papers by A. Bowman Breakdown of academic impact, for papers by Andrea Piga Breakdown of academic impact, for papers by J. Wendall Goodwin Breakdown of academic impact, for papers by D. Serin
Rankless by CCL
2026